Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Depreciation & Amortization - Total (2016 - 2020)

Ani Pharmaceuticals' Depreciation & Amortization - Total history spans 9 years, with the latest figure at $1.3 million for Q4 2020.

  • On a quarterly basis, Depreciation & Amortization - Total rose 8.33% to $1.3 million in Q4 2020 year-over-year; TTM through Sep 2021 was $1.3 million, a 72.92% decrease, with the full-year FY2025 number at $8.9 million, up 20.27% from a year prior.
  • Depreciation & Amortization - Total hit $1.3 million in Q4 2020 for Ani Pharmaceuticals, up from $1.2 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for ANIP hit a ceiling of $1.3 million in Q4 2020 and a floor of $200000.0 in Q1 2016.
  • Historically, Depreciation & Amortization - Total has averaged $680000.0 across 5 years, with a median of $500000.0 in 2018.
  • Biggest five-year swings in Depreciation & Amortization - Total: changed 0.0% in 2016 and later soared 300.0% in 2019.
  • Tracing ANIP's Depreciation & Amortization - Total over 5 years: stood at $200000.0 in 2016, then soared by 50.0% to $300000.0 in 2017, then skyrocketed by 166.67% to $800000.0 in 2018, then soared by 50.0% to $1.2 million in 2019, then increased by 8.33% to $1.3 million in 2020.
  • Business Quant data shows Depreciation & Amortization - Total for ANIP at $1.3 million in Q4 2020, $1.2 million in Q3 2020, and $1.2 million in Q2 2020.